Literature DB >> 29845055

TiO2 Nanoparticles as Potential Promoting Agents of Fibrillation of α-Synuclein, a Parkinson's Disease-Related Protein.

Soheila Mohammadi1, Maryam Nikkhah1.   

Abstract

Background: In recent years, nanomaterials have been widely used in large quantities which make people be more frequently exposed to the chemically synthesized nanoparticles (NPs). When NPs are introduced into an organism, they may interact with a variety of cellular components with yet largely unknown pathological consequences. Objective: It was found that NPs enhance the rate of protein fibrillation in the brain by decreasing the lag time for nucleation. Protein fibrillation is implicated in the pathogenesis of the several neurodegenerative diseases such as Parkinson's disease (PD). α-Synuclein (αS) is natively an unfolded protein which is involved in the pathogenesis of PD. In the present study, we have analyzed the effects of three different NPs on αS fibrillation. Materials and
Methods: αS protein expression and purifi cation was done and fibrils formation was induced in the absence or presence of the three types of NPs (i. e., TiO2, SiO2, and SnO2). The enhancement of the fluorescence emission of Thiofl avin T (ThT) and transmission electron microscopy (TEM) were used to monitor the appearance and growth of the fibrils. The adsorption of αS monomers on the surface of NPs was investigated by tyrosine fluorescence emission measurements.
Results: We found that TiO2-NPs enhances αS fibril formation even at a concentration of 5 μg.mL-1, while the two other NPs show no significant effect on the kinetics of the fibrillation. Intrinsic tyrosine emission measurement has confirmed that the TiO2-NPs interact with αS fibrillation products. It is suggested that TiO2- NPs may enhance the nucleation of αS protein that leads to protein fibril formation.
Conclusion: The fibrillization process of αS protein is profoundly affected by the presence of TiO2-NPs. This finding unveils the neurotoxicity potential of the TiO2-NPs, which may be considered as a probable risk for PD.

Entities:  

Keywords:  Nanoparticles (NPs); Parkinson’s disease (PD); Titanium Dioxide Nanoparticles (TiO2-NPs); α-Synuclein (αS)

Year:  2017        PMID: 29845055      PMCID: PMC5811058          DOI: 10.15171/ijb.1519

Source DB:  PubMed          Journal:  Iran J Biotechnol        ISSN: 1728-3043            Impact factor:   1.671


  34 in total

1.  Influence of hydrophobic Teflon particles on the structure of amyloid beta-peptide.

Authors:  Carla E Giacomelli; Willem Norde
Journal:  Biomacromolecules       Date:  2003 Nov-Dec       Impact factor: 6.988

2.  Nanoparticles as catalysts for protein fibrillation.

Authors:  Vicki L Colvin; Kristen M Kulinowski
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-14       Impact factor: 11.205

Review 3.  Multifunctional nanoparticles--properties and prospects for their use in human medicine.

Authors:  Nuria Sanvicens; M Pilar Marco
Journal:  Trends Biotechnol       Date:  2008-08       Impact factor: 19.536

4.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.

Authors:  V N Uversky; J Li; A L Fink
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

5.  Study of wild-type α-synuclein binding and orientation on gold nanoparticles.

Authors:  Jie An Yang; Brittany J Johnson; Sway Wu; Wendy S Woods; Julia M George; Catherine J Murphy
Journal:  Langmuir       Date:  2013-03-25       Impact factor: 3.882

Review 6.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

Review 7.  Filamentous nerve cell inclusions in neurodegenerative diseases.

Authors:  M Goedert; M G Spillantini; S W Davies
Journal:  Curr Opin Neurobiol       Date:  1998-10       Impact factor: 6.627

8.  A condensation-ordering mechanism in nanoparticle-catalyzed peptide aggregation.

Authors:  Stefan Auer; Antonio Trovato; Michele Vendruscolo
Journal:  PLoS Comput Biol       Date:  2009-08-14       Impact factor: 4.475

9.  One single method to produce native and Tat-fused recombinant human α-synuclein in Escherichia coli.

Authors:  Laura Caldinelli; Diego Albani; Loredano Pollegioni
Journal:  BMC Biotechnol       Date:  2013-04-04       Impact factor: 2.563

10.  Nucleation of protein fibrillation by nanoparticles.

Authors:  Sara Linse; Celia Cabaleiro-Lago; Wei-Feng Xue; Iseult Lynch; Stina Lindman; Eva Thulin; Sheena E Radford; Kenneth A Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-07       Impact factor: 11.205

View more
  7 in total

1.  Common Fatal Neurodegenerative Diseases Revisited: Beyond Age, Comorbidities, and Devastating Terminal Neuropathology There Is Hope With Prevention.

Authors:  Lilian Calderón-Garcidueñas
Journal:  Front Neurol       Date:  2022-05-11       Impact factor: 4.086

2.  Cerium oxide NPs mitigate the amyloid formation of α-synuclein and associated cytotoxicity.

Authors:  Zahra Zand; Pegah Afarinesh Khaki; Abbas Salihi; Majid Sharifi; Nadir Mustafa Qadir Nanakali; Asaad Ab Alasady; Falah Mohammad Aziz; Koorosh Shahpasand; Anwarul Hasan; Mojtaba Falahati
Journal:  Int J Nanomedicine       Date:  2019-08-29

3.  Etching of AuNPs Through Superoxide Radical Dismutation by Cu-Zn Superoxide Dismutase Resulted in Remarkable Changes of its Localized Surface Plasmon Resonance.

Authors:  Masoumeh Eghtedari; Samaneh Jafari Porzani; Masoud Javanmardi; Mohammad Reza Ganjali; Saman Hosseinkhani
Journal:  Iran J Biotechnol       Date:  2021-07-01       Impact factor: 1.671

4.  Environmental Nanoparticles Reach Human Fetal Brains.

Authors:  Lilian Calderón-Garcidueñas; Ángel Augusto Pérez-Calatayud; Angélica González-Maciel; Rafael Reynoso-Robles; Héctor G Silva-Pereyra; Andrea Ramos-Morales; Ricardo Torres-Jardón; Candelario de Jesús Soberanes-Cerino; Raúl Carrillo-Esper; Jesús Carlos Briones-Garduño; Yazmín Del Socorro Conde-Gutiérrez
Journal:  Biomedicines       Date:  2022-02-09

5.  Environmentally Toxic Solid Nanoparticles in Noradrenergic and Dopaminergic Nuclei and Cerebellum of Metropolitan Mexico City Children and Young Adults with Neural Quadruple Misfolded Protein Pathologies and High Exposures to Nano Particulate Matter.

Authors:  Lilian Calderón-Garcidueñas; Angélica González-Maciel; Rafael Reynoso-Robles; Héctor G Silva-Pereyra; Ricardo Torres-Jardón; Rafael Brito-Aguilar; Alberto Ayala; Elijah W Stommel; Ricardo Delgado-Chávez
Journal:  Toxics       Date:  2022-03-29

6.  Green Synthesis of Highly Dispersed Zinc Oxide Nanoparticles Supported on Silica Gel Matrix by Daphne oleoides Extract and their Antibacterial Activity.

Authors:  Laleh Safavinia; Mohammad Reza Akhgar; Batool Tahamipour; Sayed Ali Ahmadi
Journal:  Iran J Biotechnol       Date:  2021-01-01       Impact factor: 1.671

Review 7.  The Antiaggregative and Antiamyloidogenic Properties of Nanoparticles: A Promising Tool for the Treatment and Diagnostics of Neurodegenerative Diseases.

Authors:  Monika Pichla; Grzegorz Bartosz; Izabela Sadowska-Bartosz
Journal:  Oxid Med Cell Longev       Date:  2020-10-13       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.